Schoensiegel v. Abbott Laboratories Inc. CA2/1

CourtCalifornia Court of Appeal
DecidedMay 24, 2022
DocketB312628
StatusUnpublished

This text of Schoensiegel v. Abbott Laboratories Inc. CA2/1 (Schoensiegel v. Abbott Laboratories Inc. CA2/1) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Schoensiegel v. Abbott Laboratories Inc. CA2/1, (Cal. Ct. App. 2022).

Opinion

Filed 5/24/22 Schoensiegel v. Abbott Laboratories Inc. CA2/1 NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION ONE

CAITLIN SCHOENSIEGEL, B312628, B314633

Plaintiff and Appellant, (Los Angeles County Super. Ct. No. 19STCV21537) v.

ABBOTT LABORATORIES INC. et al.,

Defendants and Respondents.

APPEAL from a judgment and an order of the Superior Court of Los Angeles County, Barbara Ann Meiers, Judge. Affirmed. Aegis Law Firm, Samuel A. Wong and Ali S. Carlsen for Plaintiff and Appellant. Seyfarth Shaw, Joshua A. Rodine and Sumithra R. Roberts for Defendants and Respondents. —————————— Plaintiff Caitlin Schoensiegel sued her former employer, defendant and respondent Abbott Laboratories, Inc. (Abbott), alleging eight violations of the Fair Employment and Housing Act, Government Code section 12900 et seq. (the FEHA), and the California Family Rights Act (CFRA), which is contained in the FEHA, in this employment discrimination action. 1 Schoensiegel also sued her supervisor, Kiyoko Robbins (Robbins), alleging harassment. Abbott terminated Schoensiegel after an investigation determined that she had breached Abbott’s code of conduct by falsifying her sales calls log. Schoensiegel, who suffers from a rare bone disease, asserts that she was terminated because of her disability and that Abbott’s explanation is pretextual. Abbott and Robbins successfully moved the trial court for an order granting summary judgment, and Schoensiegel appeals from the judgment entered based on that order. Schoensiegel also appeals from an order awarding costs to Abbott and Robbins. We conclude that Abbott and Robbins met their burden of establishing that there is no triable issue of material fact as to any of Schoensiegel’s causes of action.2 We further conclude that Schoensiegel waived any argument that the trial court abused its discretion in awarding costs, and that the absence of written

1 All further statutory references are to the Government Code unless otherwise stated. 2 Schoensiegel does not address the trial court’s summary adjudication of her denial of leave claim under the CFRA. We therefore consider that issue waived and do not address it further herein. (Moulton Niguel Water Dist. v. Colombo (2003) 111 Cal.App.4th 1210, 1215.)

2 findings supporting the trial court’s conclusion that Schoensiegel’s action was frivolous does not require remand. Accordingly, we affirm. BACKGROUND I. Schoensiegel’s Medical Condition and Employment with Abbott Years before joining Abbott, Schoensiegel was diagnosed with polyostotic fibrous dysplasia with McCune-Albright syndrome. Individuals with this genetic condition are born with the disease in certain bones and are subject to developing lesions in those bones that render the bones more likely to fracture. Schoensiegel was hired by Abbott as a medical sales representative on June 5, 2017 by Vashti Major-Bliss (Major- Bliss), who was then the regional sales director. Abbott hired Robbins in July 2017, at which time she became Schoensiegel’s manager. Schoensiegel’s position required her to call on target accounts, which were pediatric and obstetrician offices, in order to get the doctors to recommend Abbott’s products. Representatives were also supposed to manage gratis, or samples, and distribute them to their accounts. A large part of Schoensiegel’s job was ensuring that the sample cabinets at the account offices were stocked with Abbott products and organized. Additionally, “developing rapport with everyone in the office” was a “huge aspect of the position.” Representatives were also required to be able to lift 25 pounds. In September 2017, Schoensiegel received a document outlining the district expectations. As of September 2017, Schoensiegel was aware that Robbins expected her to: (1) achieve

3 “reach” and “frequency” goals3 with respect to office calls; (2) achieve “reach” goals with respect to gratis; (3) submit expenses weekly; (4) communicate with Robbins on a weekly basis; (5) log calls into Salesforce.com (Salesforce)4 after every call; (6) conduct an average of eight to 10 office calls each day; and (7) keep physicians’ office hours, best times/days, and office call profiles up to date. The district expectations also included an expectation that sales aids were to be used on every call. Sales aids were “visual aids” that representatives “could use as additional tools to aid in [their] sales,” and included pamphlets, brochures, stickers, and iPad displays. Schoensiegel testified that sales aids could not be used over a phone call and that she did not call clients by telephone very often “[b]ecause it was expected that we try to go in person.” II. Robbins Raises Issues with Schoensiegel’s Performance In October 2017, Robbins emailed Schoensiegel asking whether she was logging calls every day. Schoensiegel replied that it was an area that needed improvement and that it would not be a problem moving forward. In December 2017, Robbins sent an email to Schoensiegel because she had failed to submit an

3 The “reach” goal refers to whether all offices assigned to the sales specialist were called on or sampled, and the “frequency” goal refers to how often offices were called. 4 Salesforceis a customer relationship management system that allows representatives and managers to input customer account information, log and view sales calls, create and view strategic account plans, and manage orders of samples to offices.

4 expense report, after previously failing to submit expense reports for several months, which had resulted in late fees. Schoensiegel first informed Robbins that she had a medical condition in December 2017 but did not state what the condition was or describe any of the symptoms to Robbins at that time. On December 21, 2017, Robbins contacted the hotline for Abbott’s employee relations department (Employee Relations) because Schoensiegel had been “taking a lot of sick time,” which she believed was affecting Schoensiegel’s performance. Robbins ultimately spoke with Karen Punzalan (Punzalan), who provided her with a list of resources. These resources included (1) Major- Bliss, (2) Abbott’s corporate policies and human resources website, (3) Matrix, Abbott’s dedicated leave of absence hotline, and (4) Employee Relations. In February 2018, Robbins sent Schoensiegel an email stating that Schoensiegel had submitted expense reports for the prior three weeks together, even though the reports were due on a weekly basis, and that this was unacceptable. Robbins asked if there was any reason why Schoensiegel could not meet that expectation, and Schoensiegel replied that she would not make any excuses and would “make the necessary expectations.” III. Schoensiegel’s Request for Accommodation In March 2018, Schoensiegel emailed Robbins a letter from her doctor addressing her need for an SUV. The letter stated: “At this time I [sic] It is my medical opinion that Caitlin Schoensiegel requires a change in her company car as she has been advised to reduce her bending and lifting. [¶] We request that you provide her an SUV or cross over to minimize the amount of bending she must do to get her samples out of the trunk or back seat. This will decrease the amount of strain

5 around her upper extremities and rib cage area. Please process this request as it is medically necessary for Ms. Schoensiegel to decrease this strain.” The letter did not contain a weight or lifting restriction, and Schoensiegel did not request one.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Harris v. City of Santa Monica
294 P.3d 49 (California Supreme Court, 2013)
Brown v. Newby
103 P.2d 1018 (California Court of Appeal, 1940)
Ballard v. Uribe
715 P.2d 624 (California Supreme Court, 1986)
Scotch v. Art Institute of California-Orange County, Inc.
173 Cal. App. 4th 986 (California Court of Appeal, 2009)
Nadaf-Rahrov v. the Neiman Marcus Group, Inc.
166 Cal. App. 4th 952 (California Court of Appeal, 2008)
Hanson v. Lucky Stores, Inc.
87 Cal. Rptr. 2d 487 (California Court of Appeal, 1999)
Trujillo v. North County Transit Dist.
63 Cal. App. 4th 280 (California Court of Appeal, 1998)
Wall Street Network, Ltd. v. New York Times Co.
164 Cal. App. 4th 1171 (California Court of Appeal, 2008)
Faust v. California Portland Cement Co.
58 Cal. Rptr. 3d 729 (California Court of Appeal, 2007)
King v. United Parcel Service, Inc.
60 Cal. Rptr. 3d 359 (California Court of Appeal, 2007)
Janken v. GM Hughes Electronics
46 Cal. App. 4th 55 (California Court of Appeal, 1996)
Kelly v. Stamps. Com Inc.
38 Cal. Rptr. 3d 240 (California Court of Appeal, 2006)
Raine v. City of Burbank
37 Cal. Rptr. 3d 899 (California Court of Appeal, 2006)
Rosenman v. Christensen, Miller, Fink, Jacobs, Glaser, Weil & Shapiro
110 Cal. Rptr. 2d 903 (California Court of Appeal, 2001)
Arteaga v. Brink's, Inc.
163 Cal. App. 4th 327 (California Court of Appeal, 2008)
Avila v. Continental Airlines, Inc.
165 Cal. App. 4th 1237 (California Court of Appeal, 2008)
Moulton Niguel Water District v. Colombo
4 Cal. Rptr. 3d 519 (California Court of Appeal, 2003)
Hernandez v. California Hospital Medical Center
93 Cal. Rptr. 2d 97 (California Court of Appeal, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
Schoensiegel v. Abbott Laboratories Inc. CA2/1, Counsel Stack Legal Research, https://law.counselstack.com/opinion/schoensiegel-v-abbott-laboratories-inc-ca21-calctapp-2022.